Sovarnum Capital’s CVS Health CVS Stock Holding History

Sovarnum Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,500	Closed	-$292K	–	72
2021 Q2	$292K	Buy	+3,500	New	+$287K	0.18%	77

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sovarnum Capital's CVS Position: Q3 2021 in Review

Sovarnum Capital sold out of CVS Health (CVS) in Q3 2021, closing a stake of 3,500 shares — an estimated $292K sold.

Sovarnum Capital first reported a position in CVS in Q2 2021 and held it in 1 quarter. The position peaked at $292K in Q2 2021. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

Sovarnum Capital reported no remaining CVS Health position as of Q3 2021 after selling out during the quarter.
Sovarnum Capital sold 3,500 CVS Health shares in Q3 2021, an estimated $292K.
Sovarnum Capital first reported a position in CVS Health in Q2 2021 and held it in 1 quarter.
Sovarnum Capital's CVS Health position peaked at $292K in Q2 2021.
2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Sovarnum Capital's 13F filing for Q3 2021, filed 8 Nov 2021.